Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Nov-22 9:10 PM View:  | Foehr Matthew W CLO & Secretary Director | Omniab, Inc. (NONE) | 01-Nov-22 | Disposition | 212,362 | -- | -- | (100%) 212.36K to 0 | |
| 03-Nov-22 9:13 PM View: | Gustafson Kurt A EVP, Finance and CFO | Omniab, Inc. (NONE) | 01-Nov-22 | Grant | 17,792 | -- | -- | 100% 0 to 17.79K | |
| 03-Nov-22 9:13 PM View: | Gustafson Kurt A EVP, Finance and CFO | Omniab, Inc. (NONE) | 01-Nov-22 | Disposition | 17,792 | -- | -- | (100%) 17.79K to 0 | |
| 03-Nov-22 9:08 PM View: | Berkman Charles S CLO & Secretary Director | Omniab, Inc. (NONE) | 01-Nov-22 | Grant | 15,409 | -- | -- | 41% 37.18K to 52.59K | |
| 03-Nov-22 9:08 PM View: | Berkman Charles S CLO & Secretary Director | Omniab, Inc. (NONE) | 01-Nov-22 | Disposition | 52,587 | -- | -- | (100%) 52.59K to 0 | |
| 03-Nov-22 9:12 PM View: | Ligand Pharmaceuticals Inc 10% Owner | Omniab, Inc. (NONE) | 01-Nov-22 | Disposition (other) | 16,859,300 | -- | -- | (100%) 16.86M to 0 | |
| 03-Nov-22 9:10 PM View: | Foehr Matthew W CLO & Secretary Director | Omniab, Inc. (NONE) | 01-Nov-22 | Grant | 26,193 | -- | -- | 14% 186.17K to 212.36K |
